Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma
Paul H. Huang(Institute of Cancer Research), Forest M. White(Center for Cancer Research), Rudy Bonavia(Ludwig Cancer Research), Frank B. Furnari(University of California San Diego), Webster K. Cavenee(University of California San Diego), Zachary E. Brewer(Biological E (India)), Ryan A. Flynn(Boston Children's Hospital), Akitake Mukasa(Kumamoto University Hospital)
Cited by 390
Related Papers
Malignant astrocytic glioma: genetics, biology, and paths to treatment
|Genes & Development|2007|2.3k
The WHO Classification of Tumors of the Nervous System
|Journal of Neuropathology & Experimental Neurology|2002|2k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945